Article
Mesenchymal stromal cell therapy in ischemic heart disease.
Scandinavian cardiovascular journal : SCJ - 1 Jan 2000
Kastrup Jens, Mygind Naja Dam, Qayyum Abbas Ali, Mathiasen Anders Bruun, Haack-Sørensen Mandana, Ekblond Annette
Abstract excerpt
Although, treatment of ischemic heart disease (IHD) has improved considerably within the last decades, it is still the main cause of death worldwide. Despite maximum treatment, many IHD patients suffer from refractory angina and heart failure, which severely limits their daily lives. Moreover, IHD is very costly for the health care system. Therefore, new treatment options and strategies are being researched...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
